PaLM Conf Minutes 2021-February-10: Difference between revisions
Jump to navigation
Jump to search
| Line 44: | Line 44: | ||
'''Next meeting: March 10, 2021''' | '''Next meeting: March 10, 2021''' | ||
#Agenda was reviewed | #Agenda was reviewed | ||
Latest revision as of 19:04, 23 February 2021
Attendees
| Name | |
|---|---|
| Francois Macary | Francois.macary@phast.fr |
| Rikki Merrick | rikimerrick@gmail.com |
| Alessandro Sulis | Allesandro.sulis@crs4.it |
| Dan Rutz | drutz@epic.com |
| Kevin Schap | kschap@cap.org |
| Francesca Vanzo | fvanzo@consorzioarsenal.it |
| Filip Migom | Filip.migom@mips.be |
| Jim Harrison | james.harrison@virginia.edu |
| Ralf Herzog | ralf.herzog@roche.com |
| JD Nolen | jdlnolen@gmail.com |
| Francesca Frexia | Francesca.frexia@crs4.it |
| Nick Haarselhorst | nick.haarselhorst@philips.com |
| Mary Kennedy | mkenned@cap.org |
| Gunter Haroske | haroske@icloud.com |
| Rajnish Bhatt | |
| Alex Goel | agoel@cap.org |
| Gregorio Canal | Arsenal.IT |
| Gianluca Pavan | Arsenal.IT |
| Will Humphrey |
Next meeting: March 10, 2021
- Agenda was reviewed
- Election results
- Alessandro is the new Technical Co-Chair
- Riki retains her Planning Co-Chair position
- Many thanks to Francois for his decades of service as Technical Co-Chair
- Next F2F meeting
- Tentatively planned around May 31- June 2, 2021 in Belgium
- We will decide in March if we should postpone the F2F for a few more months and depending on Filip’s schedule. However, Filip stated he will not be able to attend the March 10 PaLM call.
- SET update
- https://mail.google.com/mail/u/0/?tab=cm#inbox/FMfcgxwLsSXWPWsTSCVpGJZbppCLtBjr
- If SAC belongs to the SPM, then do not use the SAC-3 element, as it is the same as SPM-2 element – Apply this to all message examples
- At HL7 WGM, discussion around not providing SPM information IF the specimen collection failed; but it is hard to describe something that doesn’t exist
- Specimen processing – with derived specimen
- Aliquoted specimen:
- Is in the same message with the parent specimen for the processing step, but after that it is handled as a new specimen
- Use of the SGH/SGT for derived specimen works well
- Pathology specimen
- Need multiple SGH/SGT support
- Aliquoted specimen:
- Question:
- Would we ever have a specimen with multiple containers?
- If collect 24-hour urine in 2 bottles:
- Using the same SPM-ID on the containers
- If collect 24-hour urine in 2 bottles:
- Would we ever have a specimen with multiple containers?
- Next step:
- All to review all other examples and provide feedback by next week COB Tuesday (2/16/2021)
- Bring the Change Request to HL7 OO WG for introduction tomorrow at end of call and then bring back for vote a week later
- New proposal updates:
- Telemedicine
- Reviewing the draft document: https://docs.google.com/document/d/1raJKfBhct20uO0jUk3zJYS3XcSxj77G-iSsiLNTPvbs/edit?usp=sharing
- Francesca will be on maternity leave over the summer (congratulations!)
- Next Steps:
- All to review the diagram and provide feedback to the group by EOD 2/24/2021
- Radiology and Pathology concordance work
- Looking for consistent meeting time for weekly or biweekly calls – aiming for Wednesdays/Thursdays/Fridays in the morning ET
- Have some vendors interested in those timeslots
- Shared proposed timeline:
- Set up calls by end of next week
- Draft outline in IHE template by Early March
- Prostate cancer checklist completed by end of Feb / March
- Bring new actors to the DCC – aim for March or April
- Profile to be submitted for Public Comment by July 23, 2021 (*adjusted from Aug 1, 2021 to allow for more PC time)
- Profile to be submitted to PaLM for vote and publication for Trial Use September 20, 2021
- Riki will update the publication timeline and notify Mary Jungers
- Looking for consistent meeting time for weekly or biweekly calls – aiming for Wednesdays/Thursdays/Fridays in the morning ET
- Telemedicine
- Approval of CP 266 (submitted by Ralf)
- Add supplemental results to POCT testing similar to what we allow in LAW
- Use links to sections in the LAW profile
- Motion to approve this CP – Ralf Herzog, Francois Macary, no further discussion, against: 0, abstain: 1, in favor: 13. Motion passed.